Docket

40400

Pharmascience Inc. v. Bristol-Myers Squibb Canada Co, Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.

(Federal) (Civil) (By Leave)

Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.

Proceedings
Date Proceeding Filed By
(if applicable)
2023-04-14 Close file on Leave
2023-03-30 Copy of formal judgment sent to Registrar of the Court of Appeal and all parties
2023-03-30 Judgment on leave sent to the parties
2023-03-30 Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Numbers A-31-21 and A-32-21, 2022 FCA 142, dated August 4, 2022 is dismissed with costs.
Dismissed, with costs
2023-02-27 All materials on application for leave submitted to the Judges, for consideration by the Court
2022-12-01 Certificate (on limitations to public access), (Letter Form), 23B, (Printed version filed on 2022-12-02) Pharmascience Inc.
2022-12-01 Applicant's reply to respondent's argument, (Book Form), Completed on: 2022-12-08, (Printed version filed on 2022-12-02) Pharmascience Inc.
2022-11-21 Notice of name, (Letter Form), (Printed version due on 2022-11-28) Bristol-Myers Squibb Canada Co, Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.
2022-11-21 Certificate (on limitations to public access), (Letter Form), 23A, (Printed version due on 2022-11-28) Bristol-Myers Squibb Canada Co, Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.
2022-11-21 Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2022-11-23, (Printed version filed on 2022-11-21) Bristol-Myers Squibb Canada Co, Bristol-Myers Squibb Holdings Ireland Unlimited Company and Pfizer Inc.
2022-10-21 Letter acknowledging receipt of an incomplete application for leave to appeal, FILE OPENED 2022-10-21
2022-10-03 Supplemental document, (Letter Form), Canadian Patent, (Printed version due on 2022-10-11) Pharmascience Inc.
2022-10-03 Notice of name, (Letter Form), (Printed version due on 2022-10-11) Pharmascience Inc.
2022-10-03 Certificate (on limitations to public access), (Letter Form), 23B, (Printed version due on 2022-10-11) Pharmascience Inc.
2022-10-03 Certificate (on limitations to public access), (Letter Form), 23A, (Printed version due on 2022-10-11) Pharmascience Inc.
2022-10-03 Application for leave to appeal, (Book Form), Required:
Order of the Federal Court (Rec'd 2022-10-27), Completed on: 2022-12-05, (Printed version filed on 2022-10-04)
Pharmascience Inc.